Ditchcarbon
  • Contact
  1. Organizations
  2. OriGene Technologies, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 months ago

OriGene Technologies, Inc. Sustainability Profile

Company website

OriGene Technologies, Inc., a leading biotechnology company headquartered in the United States, has been at the forefront of molecular biology since its founding in 1996. With a strong presence in North America, Europe, and Asia, OriGene focuses on providing innovative solutions in gene expression, protein production, and antibody development. The company is renowned for its extensive portfolio of high-quality products, including cDNA clones, antibodies, and gene expression assays, which are designed to accelerate research in genomics and proteomics. OriGene's commitment to quality and innovation has positioned it as a trusted partner for researchers and institutions worldwide. Notable achievements include the development of unique technologies that enhance the accuracy and efficiency of gene analysis, solidifying OriGene's reputation as a key player in the biotechnology industry.

DitchCarbon Score

How does OriGene Technologies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

OriGene Technologies, Inc.'s score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.

27%

Let us know if this data was useful to you

OriGene Technologies, Inc.'s reported carbon emissions

OriGene Technologies, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. As of now, there are no emissions figures, such as Scope 1, 2, or 3 emissions, nor any commitments to science-based targets (SBTi) or other climate pledges. In the absence of specific data, it is important to note that many companies in the biotechnology sector are increasingly focusing on sustainability and reducing their carbon footprints. However, without concrete information from OriGene Technologies, Inc., it is not possible to provide a detailed overview of their climate commitments or performance.

How Carbon Intensive is OriGene Technologies, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. OriGene Technologies, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is OriGene Technologies, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for OriGene Technologies, Inc. is in US, which has a low grid carbon intensity relative to other regions.

OriGene Technologies, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

OriGene Technologies, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare OriGene Technologies, Inc.'s Emissions with Industry Peers

Sigma-Aldrich Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Ginkgo

US
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Blue Heron Biotechnology, Inc.

US
•
Research and development services (73)
Updated 1 day ago

Cobra Biologics Limited

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Juno Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Agilent

US
•
Other services (93)
Updated 9 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251118.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy